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ABSTRACT 
In recent years concern has grown over the quality of indoor air, 
and its possible effects on human health. Particular interest is 
given to the chemical Formaldehyde, and the concentrations found in 
the domestic and health care environments. 
Because of this a study was initiated to determine the 
Formaldehyde concentration in the air of various health care 
institutions. 
Sampling was done in three institutions: a nursing home, a 
hospital, and a university health service. In the nursing home the 
average concentration of Formaldehyde was 88 PPB in a patient room, 
127 PPB in a hall, and 145 PPB in a lounge. The average 
concentrations in the hospital were 155 PPB in a patient room, 32 PPB 
in a hall, and 68 PPB in a solarium. The university health service 
was found to have Formaldehyde levels of 180 PPB in a patient room, 
192 PPB in a hall, and 200 PPB in a lounge. 
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CHAPTER I 
INTRODUCTION 
Formaldehyde is a one-carbon compound (HCHO) which at room 
temperature is normally in the highly reactive gaseous state and is 
characterized by a pungent odor. 
In 1982, approximately six billion pounds of Formaldehyde were 
produced in the United States (1). Most of this was used in the 
production of Urea-, Phenol-, Acetal- and Mel amine-formaldehyde 
resins. These resins are used as adhesives in the manufacture of 
particle board, veneers and plywood; and in the production of 
insulating materials, plastics, textiles, protective coatings, paper 
and rubber products. In addition. Formaldehyde is used in the 
manufacture of industrial chemicals, agricultural products, leather 
goods and as a preservative for cosmetics, drugs, vaccines, fumigants 
and disinfectants (2). 
The commercial form of Formaldehyde (Formalin) is a 37 to 50 
percent aqueous solution which is stabilized against polymerization 
with 1 to 15 percent methanol. Formaldehyde is also available as a 
solid linear polymer containing 5 to 9 percent water. 
Formaldehyde can be released indoors from any of the 
aforementioned products (3). It is also a component of cigarette 
smoke (4). 
As indicated above, indoor concentrations of Formaldehyde are of 
great interest to the health care industry, especially in nursing 
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homes, hospitals, and other patient facilities. Within these confines 
a unique situation exists in that one is treating ill or infirm 
individuals who are already under physical stress. While a healthy 
person may easily tolerate Formaldehyde levels up to 3.0 
parts-per-million (PPM), patients who are ill may be far less tolerant 
(5). This is especially true for those suffering from respiratory 
ailments, or asthmatic patients (5). 
Because of this situation and the lack of definitive data 
regarding the amounts of Formaldehyde in the air of health care 
facilities, the present study was undertaken. 
CHAPTER II 
LITERATURE REVIEW 
Humans are susceptible to adverse health effects from acute 
Formaldehyde exposure. Between 0.1 PPM up to 3.0 PPM, most experience 
an irritation of the eyes, nose and throat (5, 7). This is 
characterized by sneezing, tearing, shortness of breath, nausea, 
sleeplessness, tightness of the chest and excess phlegm (8). Cases 
have also been reported where asthma has been attributed to exposure 
to low levels of Formaldehyde (6, 9). In terms of exposure to higher 
concentrations (4-5 PPM), it has been reported that this can be 
tolerated for 10 to 30 minutes, after which pulmonary edema and death 
can result. From 10.0 PPM to 20.0 PPM respiration becomes difficult, 
and exposure to levels at or above 50.0 PPM can cause pulmonary edema 
and pneumonitis (10). 
While Formaldehyde is extremely reactive and could very well be 
the subject of a comprehensive discussion regarding the dynamics of 
chemical reactions, the following have been selected to illustrate the 
chemical interplay of Formaldehyde with such products as water, 
ammonia, amines and amids: components of all biological systems (11). 
HCHO + H20 = CH2(0H)2 (a) 
RNH2 + HCHO = RNHCH20H (bl) 
RNHCH20H + R'NH2 = RNHCH2NHR' + H20 (b2) 
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RC0NH2 + HCHO = RC0NHCH20H (cl) 
RC0NHCH20H + R'CONH2 = RCONHCH2NHOCR' + H20 (c2) 
These reactions are of concern because of the occurrence of Nitrogen 
compounds (DNA, RNA, Amino Acids and Proteins) in all biological 
systems. It is not surprising, therefore, that the chronic effects of 
Formaldehyde exposure have been under investigation. 
Formaldehyde has been shown to have teratogenic effects: that 
is, an effect on the developing embryo. As early as 1968, Gofmekler 
exposed pregnant female rats to Formaldehyde levels of 0.0, 0.012, and 
1.0 mg/M (12), and showed that pups from both exposure groups had 
livers and lungs which weighed less than those from the control group. 
Again in 1969 Gofmekler examined the livers and kidneys of pups born 
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to female rats exposed to 1.0 mg/M of Formaldehyde (13). He 
found that those from the exposure group had changes in the liver, 
including an increase in epithelial cells in the bile duct. The 
kidney changes included casts in the lumina of some tubules and 
alteration of the renal tubules. There was also noted an involution 
of the thymus lymphoid tissue, and a disintegration of lymphocytes in 
pups from the exposure group. In a dietary study, pregnant beagles 
were fed levels of Hexamethylenetetramine (HMT) amounting to 600 and 
1250 PPM (14). HMT is an antimicrobial food additive which degrades 
to Formaldehyde and Ammonia in the presence of protein, or in the acid 
medium of the digestive tract (15). It was found that while 600 PPM 
had no discernible effect (14), 1250 PPM of HMT had a noticeable 
effect on the beagle pups. In the 1250 PPM exposure group there was a 
greater percentage of stillborn pups, and those that survived grew at 
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a less-than-normal rate. In humans, Formaldehyde was shown to have 
teratogenic and adverse reproductive effects. Two female exposure 
groups of 130 fabric trim shop finishers and 316 fabric warehouse 
inspectors were compared with one control group of 200 industrial 
goods saleswomen (16). The atmospheric concentrations of Formaldehyde 
in the trim shops ranged from 1.5 to 4.5 mg/M3; the warehouse 
levels ranged from 0.05 to 1.0 mg/M3. Forty-seven and one-half 
percent of the exposure groups had menstrual disorders, as compared to 
18 percent of the control group. Those who were pregnant in the 
exposure groups had twice as many instances of intrauterine 
asphyxiation and a greater percentage of babies with low birth 
weights. 
Formaldehyde has also been shown to have mutagenic properties. 
In one study. Drosophila larvae were fed Formaldehyde-treated food 
which resulted in a 6 percent occurrence of sex-linked recessive 
lethal mutations, against 0.2 percent for a control group (17). 
Formaldehyde-treated food has also produced mutations in the alcohol 
dehydrogenase (ADH) gene of Drosophila (18). Injections of weak 
Formaldehyde solutions into adult Drosophila have also produced 
sex-linked recessive lethal mutations but at a much lower frequency 
than those for Formaldehyde-treated food (19,20). 
The potential carcinogenicity of Formaldehyde has also been 
investigated. In an inhalation study, groups of 240 rats (120 males 
and females per group) were exposed to 0.0, 2.1, 5.6 and 14.1 PPM of 
Formaldehyde. After 24 months, the cancer totals were inventoried by 
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autopsy. Exposure to 14.1 PPM resulted in 93 nasal squamous cell 
carcinomas, four squamous papilloma, three adenomatous polyps, and two 
carcinomas of the respiratory epithelium. Two of those exposed to 5.6 
PPM developed nasal squamous cell carcinomas, four developed 
adenomatous polyps, and one developed carcinoma of the respiratory 
epithelium. Two in the 2.1 PPM exposure group developed adenomatous 
polyps (21). In another inhalation study, groups of 240 rats or mice 
(120 males and females per group) were exposed to Formaldehyde levels 
of 0.0, 2.0, 5.6 and 14.3 PPM (22). Formaldehyde-induced lesions were 
noted in the nasal cavity and trachea. After 27 months, the cancer 
totals were as follows; in the 14.3 PPM exposure group, 103 rats and 
2 mice developed nasal squamous cell carcinomas, as well as 2 rats in 
the 5.6 PPM exposure group. 
Because Formaldehyde is a strong irritant and is considered a 
potential carcinogen in humans, concern has been voiced in recent 
years as to what the airborne concentrations are in the workplaces and 
places of habitation. When a high concentration of Formaldehyde 
exists in a workplace, it can be dealt with using established 
industrial hygiene techniques. These techniques include the use of 
ventilation systems, containment of the source, filtration, 
absorbance, and substitution of other chemicals. In many places of 
habitation or in health care facilities it is often difficult to cope 
with formaldehyde, since the levels would never approach those of an 
industrial process which employs Formaldehyde directly and very often 
no one is aware that a given product contains or releases Formaldehyde 
7 
(23). 
Various groups have recommended occupational standards for 
Formaldehyde. The National Institute for Occupational Safety and 
Health (NIOSH) has suggested a workplace limit of 1 PPM (24). The 
American Conference of Governmental Industrial Hygienists (ACGIH) has 
recommended a threshold limit value (TLV) of 2 PPM. A TLV is the 
concentration which it is believed the majority of workers may be 
repeatedly exposed eight hours each day with no adverse effect (25). 
The Occupational Safety and Health Administration (OSHA) is the only 
Federal agency authorized to set and enforce standrds. For this 
purpose, OSHA has set a 3 PPM permissible exposure limit (PEL) for 
Formaldehyde, for an eight hour workshift, a ceiling concentration of 
5 PPM, and a peak concentration of 10 PPM (26). 
CHAPTER III 
METHODS 
For the purposes of this study three sampling locations were 
chosen: a hospital, a nursing home, and a university health service. 
Ten samples were taken from three different areas inside each 
institution: a patient room, a corridor in a patient area, and a 
patient common area, such as a lounge or solarium. In all areas, the 
ceiling heights ranged from 2.5 to 3 meters. The patient rooms were 
all approximately 7 by 4 meters, with a volume of around 65,000 
liters. The solarium/lounge areas varied from 9 by 5 to 11 by 8 
meters, giving an approximate volume between 100,000 and 200,000 
liters. The corridors varied in length, from 3 by 6 to 3 by 12 
meters, for an approximate volume between 45,000 and 90,000 liters. 
The air temperature was taken at the beginning and end of each sample. 
The average was used in the calculation of the PPM concentration of 
Formaldehyde in the air. During each sampling period it was also 
noted if anything was occurring which might elevate the levels of 
Formaldehyde, such as smoking or use of a disinfectant. 
Samples were collected between November 1, 1983 and January 9, 
1984. The samples were taken during the hours of 7:00 A.M. and 9:00 
P.M. 
Air sampling was performed using an impinger sampling train. The 
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sampling pump used was an MSA personal sampling pump calibrated and 
set to run at 1 liter per minute (LPM). All tubing in the sampling 
train was FEP Teflon. Two 30 milliter impingers were used. They were 
connected in series, and each contained 20 milliters of distilled, 
deionized water for every sample. With the impingers in series, the 
collection efficiency is 95% (24). The sampling apparatus was placed 
on a cart or chair to elevate it between one-half to one meter above 
the floor. When possible, the samples from a patient room were taken 
in an empty room, so as not to inconvenience patients or staff. 
Analysis of samples was carried out using the modified 
pararosaniline method for determining the concentration of 
Formaldehyde in air (27). To analyze each sample a 2.5 milliter 
aliquot was placed into a one centimeter cuvette, to which was added 
0.25 milliters of the acidified Pararosaniline reagent. To this was 
added 0.25 milliters of a 0.1 gram/100 milliters Sodium Sulfite 
reagent. The cuvette was capped and shaken to insure complete mixing, 
and developed in a 25°C water bath for one hour. After 
developing, the samples were read using a Coleman 124 double beam U.V. 
and visible spectrophotometer (Perkin & Elmer) set at 570 nanometers. 
Each sample was read against a distilled water blank. All associated 
glassware was acid washed and rinsed with distilled, deionized water 
prior to use. 
CHAPTER IV 
RESULTS 
Data 
The following tables are a listing of individual measurements for 
Formaldehyde in each of the three institutions studied. Since the 
modified pararosaniline method has a lower detection limit of 25.0 
parts-per-billion (0.025 PPM), values obtained that were lower than 
this were not included in the figuring of averages (27). 
Location Room Hall Lounge 
130 164 191 
96 142 122 
62 231 215 
Formaldehyde 65 236 167 
levels in PPB 62 145 142 
99 153 186 
131 54 150 
106 58 120 
73 40 84 
58 47 110 
Mean 88 127 149 
Median 84.5 143.5 146 
Standard Deviation 28.1 74 41 
Variance 792 5483.3 1686. 
Ambient (outside) Formaldehyde levels: 29 PPB 
Table 1. Nursing Home Formaldehyde Levels. 
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Location 
Formaldehyde 
levels in PPB 
Mean 
Median 
Standard Deviation 
Variance 
Room Hall Solarium 
276 31 131 
281 16* 62 
138 25 78 
99 27 31 
133 41 44 
105 25 70 
120 37 24* 
112 10* 58 
164 36 5* 
124 33 4* 
155 32 68 
128.5 29 62 
67.5 5.9 32 
4560 35.3 1025.5 
Ambient (outside) Formaldehyde levels: 10* PPB 
* These levels were below the lower limit of detection. 
Table 2. Hospital Formaldehyde Levels. 
Location Room Hall Solarium 
393 384 393 
322 365 334 
138 196 269 
Formaldehyde 113 251 292 
levels in PPB 363 59 80 
77 55 94 
89 51 250 
76 202 91 
180 217 96 
129 144 103 
Mean 188 192 200 
Median 133.5 199 176.5 
Standard Deviation 123.3 120 119.6 
Variance 15215.7 14406 14296.8 
Ambient (outside) Formaldehyde levels: 27 PPB 
Table 3. Health Services Formaldehyde Levels. 
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Formaldehyde 
in PPB 
200 
100 
192 200 
188 - - 
155 
Room Hall Solarium/Lounge 
Nursing Home 
Hospital 
Health Service 
Graph 1. A Comparison 
Health Care 
of Average Levels 
Institutions. 
of Formaldehyde in the Three 
CHAPTER Y 
DISCUSSION 
As can be seen from the study data, the Formaldehyde levels 
ranged from below detectability (25 PPB) to a high of 393 PPB. The 
levels observed never approached the limits set by OSHA. This may be 
due in part to the age of the buildings and the type of insulation 
used. The hospital wing was built in 1959, the health service in 
1972-1973 and the nursing home in 1967. The Formaldehyde content of 
any potential source, such as floor tile and plywood, has decreased 
over the years. This means that these older materials will contribute 
little if any to the indoor Formaldehyde levels. The type of 
insulation used can also contribute significant amounts of 
Formaldehyde. In all three institutions, an insulating material other 
than Urea-Formaldehyde foam insulation (UFFI) was used. Therefore, we 
can rule out the insulation as a Formaldehyde source. The 
disinfectants and cleansers used in each institution were also found 
not to contain Formaldehyde, in the form of Formalin. They did 
contain Tetrasodium Ethylenediamine tetraacetate (EDTA), which is 
known to have Formaldehyde as a contaminant (22). The other probable 
sources of Formaldehyde were the obvious ones: plastics, foam 
mattresses, synthetic clothing, and paper and rubber products. 
The Formaldehyde levels measured could cause irritation to the 
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eyes and upper respiratory tract in humans. They could also aggravate 
an asthmatic condition. To a healthy employee this would only be a 
minor discomfort: indeed some individuals might not exhibit any 
symptoms. Furthermore, most employees work an average of 8 hours each 
day and are not being continuously exposed. The patient is the 
antithesis of this. Due to age or illness, or both, the patient is in 
a physically-stressed situation. This is especially true if a patient 
is suffering from respiratory ailments. The minor irritations that 
sometimes result from exposure to low levels of Formaldehyde might 
instead act synergistically with the illness(es) already present, 
causing major ramifications. 
CHAPTER VI 
CONCLUSION 
The modified pararosaniline method for the determination of 
Formaldehyde concentration in the air seemed well-suited for the use 
in locations such as health care facilities. The compact size of the 
sampling apparatus, the small (quiet) sampling pump needed and the 
a 
relative immunity to false positive or negative readings support this. 
The levels of Formaldehyde measured indicate the presence of 
Formaldehyde in three different types of health care facilities. 
Readings never approached the OSHA standard, which indicates the 
patients in the institutions studied were not in any overtly hazardous 
situation. However, the potential for irritation to the respiratory 
system of both staff and patient exists, on the basis of individual 
measurements. 
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CHAPTER VII 
RECOMMENDATIONS 
There should be a concerted effort on the part of health care 
facilities to do everything possible to reduce the levels of 
Formaldehyde present. One method would be to air out or launder all 
new linens, curtains, foam mattresses, etc., before use in a patient's 
room. This would act to reduce the amount of Formaldehyde the 
material has available for release to the indoor environment. Small 
air purifier pumps containing chemical filters could also be used to 
remove the Formaldehyde already present. 
By so doing, the Formaldehyde levels would reduced, and thus 
decrease the possibility of the patients being adversely affected by 
this one component of indoor air pollution. 
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APPENDIX A 
Preparation of Pararosaniline Stock Solution 
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Reagents: 
1) IN Hydrochloric acid (HCL). Dilute 83 ml of concentrated Hydro¬ 
chloric acid, ACS Reagent Grade, to one liter with distilled 
water in a one-liter volumetric flask. 
2) 1-Butanol. 
3) Pararosaniline Hydrochloride, purchased from Aldrich (catalog 
no. 21,559-7). 
Apparatus: 
1) 2-liter separatory funnel (two). 
2) 2-liter stoppered flask (two). 
3) Magnetic stirrer. 
4) Magnetic stirring bars. 
Procedure: 
I. Cleaning of Glassware. 
All glassware was cleaned by soaking in a 5N Nitric acid solution 
for at least one hour. Rinsing was then done using distilled, 
deionized water. The glassware was dried in a 40°C oven. 
II. Pararosaniline Solution Preparation. 
750 ml of IN HCL and 750 ml of 1-Butanol is placed in a 2-liter 
stoppered flask. A magnetic stirring bar is added, and the mixture is 
allowed to equilibrate for 24 hours. After equilibrating, the HCL and 
1-Butanol are separated using a 2-liter separatory funnel. 1.5 grams 
of Pararosaniline Hydrochloride is added to 750 ml of the equilibrated 
HCL in a 2-liter flask. A magnetic stirring bar is added, and the 
21 
Pararosaniline is allowed to dissolve for 24 hours. After 24 hours, 
400 ml of the equilibrated 1-Butanol is added to the flask. This is 
allowed to mix for 24 hours. After 24 hours, the mixture is 
transferred to a 20 liter separatory funnel, and extracted. The lower 
(aqueous) phase is saved in a 2-liter flask. The upper (organic) 
phase is discarded. The extractions are repeated four more times, 
with one 100 ml and three 50 ml portions of the equilibrated 
1-Butanol. Each extraction is allowed to mix for 24 hours. After the 
final extraction, the lower (aqueous) phase is placed in a 1-liter 
flask, and labeled. This Pararosanil ine reagent is used to develop 
the Formaldehyde samples. 
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APPENDIX B 
Standardization of Formalin Solution 
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Reagents: 
1) Formalin solution (37% w/w), purchased from Fisher Scientific 
(catalog no. F-79). 
2) Formaldehyde solution 'A'. Dilute 3.0 ml of the 37% Formalin 
solution to one liter with distilled water. 
3) Formaldehyde solution 1B'. Dilute 1 ml of standard solution 'A' 
to 100 ml with distilled water. This solution must be prepared 
fresh daily for use in preparation of the calibration curve (see 
Appendix C). 
4) IN Sodium Sulfite (Na^SO^). Weigh 31.5 g of anhydrous 
Sodium Sulfite (Fisher catalog no. S-430) and add to a 250 ml 
volumetric flask. Fill to the mark with distilled water. 
5) IN Hydrochloric acid. Dilute 83 ml of concentrated Hydrochloric 
acid, ACS reagent grade, to one liter with distilled water in a 
one-liter volumetric flask. 
6) IN Hydrochloric acid (HCL), standardized for titrations. This is 
prepared as in (5) above. This solution is standardized with IN 
Sodium Hydroxide, which was previously standardized with 
Potassium Biphthalate. 
7) IN Sodium Hydroxide (NaOH). Weigh out 40.0 g of Sodium Hydroxide 
(ACS grade) in a 1-liter volumetric flask. Fill to the mark with 
distilled water. 
8) 0.1N HCL. Dilute 1 ml of the standardized IN HCL solution to 100 
ml with distilled water. 
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Apparatus: 
1) pH meter (Orion digital model 701) calibrated with pH 7.00 buffer 
solution. 
2) pH electrode (Markson no. 739 combination electrode). 
3) Magnetic stirrer. 
4) Magnetic stirring bars. 
5) 200 ml beaker. 
6) Disposable eye droppers. 
7) 25 ml volumetric pipette (three). 
8) 50 ml graduated cylinder. 
9) 100 ml beaker (three). 
10) 25 ml burette (two). 
Procedure: 
I. Cleaning of Glassware. 
All glassware was cleaned by soaking in a 5N Nitric acid solution 
for a least one hour. Rinsing was then done using distilled, 
deionized water. The glassware was dried in a 40°C oven. 
II. Standardization of Formaldehyde Solution 'A' 
The pH meter is used as the indicator for all titrations 
performed. Approximately 100 ml of Formaldehyde solution'A' is 
neutralized (pH 7.00) with unstandardized IN HCL while being stirred 
slowly with a magnetic stirrer. Next, 50 ml of IN Na^SO^ is 
neutralized with unstandardized IN HCL while being stirred slowly on a 
magnetic stirrer. A 25 ml aliquot of the neutralized Formaldehyde is 
then added to the 50 ml of neutralized Na^SO^ 
25 
solution. This mixture is back-titrated with standardized 0.1N HCL to 
neutral pH. The titration is repeated at least two more times, and 
the results averaged. The average obtained is then used to calculate 
the concentration of Formaldehyde in solution 'A'. 
Results: 
The standardized HCL solution was 1.0064N. Therefore the 1:10 
dilution was 0.10064N HCL. The average milliters used was 18.436. 
The following equation (28) is used to calculate the concentration of 
Formaldehyde in mg/ml. 
,u A ml HCL X N HCL v 30.03 mg/ml 
CH20 (mg/ml) - m1 Formalin X H* 
Substituting in the known figures into the equation, we find that 
the concentration of Formaldehyde in solutin 'A' is 2.2287 mg/ml. 
18.436 ml HCL X 0.10064N HCL v 30.03 mq/ml 0 
-?5'mV Formalin-x-ST-=2’2287 
The concentration of Formaldehyde in solution 'B’ is 0.01 times 
that of solution 'A'. 
Solution 'A' = 2.2287 mg/ml 
Solution 'B1 = 0.022287 mg/ml 
Solution 'B1 = 22.287 yg/ml 
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APPENDIX C 
Preparation of Calibration Curve 
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Reaaents: 
- 
1 ^ararosaniline stock solution. This was prepared in Appendix A. 
2) Formaldehyde solution 'B'. Dilute 1 ml of standardized 
Formaldehyde solution 'A' to 100 ml with distilled water (see 
Appendix B). This solution must be made fresh daily for use in 
precaring the calibration curve. 
3) Sodium Sulfite (Wa2S03) solution. Dissolve 0.1 grams in 
IOC nl of distilled water. This solution must be prepared fresh 
weekly. 
Apparatus: 
1 1 centimeter cuvettes. 
2) h i^mer Coleman 125 double beam U.Y. and visible spectro¬ 
photometer 'or equivalent) set at 570 nanometers. 
3) Water bath, set at 25° Celsius. 
a 5 nl pipettes. 
5) 1 ml pipettes. 
^ocec ure: 
standards are prepared by first pipetting 0.0, 0.025, 0.05, 
3-10, 0.20, C.25 and 0.30 ml of Formaldehyde solution 1B' into 1 cm 
:Bettes. Disti ed water is added to each cuvette to make the volume 
-p to 2.50 nl. "he 0.25 nl of the acidified Pararosaniline reagent is 
acted, and the cuvette is capped and shaked to insure complete mixing. 
**ter nixing, 0.25 m' of the Sodium Sulfite solution is added. The 
c-.ette is p'aced in the 25X water bath, and allowed to develop 
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for one hour. The cuvettes can be read up to three hours after 
developing, but it is best to read them immediately. 
The standards are read against a distilled water blank, and the 
average of two readings is used in preparing the calibration curve. 
No. 
CH 0 
ml 2 
H 0 
ml 2 
X of 2 
Absorb. 
yg/2.5/ml 
CH 0 
2 
yg/ml 
CH 0 
2 
(yg/ml = yg 
in 2.5 ml 
divided by 
2.5) 
1 0.000 2.500 0.355 0.000 0.000 
2 0.025 2.475 0.379 0.450 0.180 
3 0.050 2.450 0.514 0.901 0.360 
4 0.100 2.400 0.620 1.801 0.720 
5 0.150 2.350 0.783 2.702 1.081 
6 0.200 2.300 0.921 3.602 1.441 
7 0.250 2.250 1.018 4.503 1.801 
8 0.300 2.200 1.117 5.403 2.161 
Least squares line: 
X axis Slope Intercept Correlation 
yg in 2.5 ml 0.1470 0.35756 0.9951 
y g/ml 0.3675 0.35760 0.9951 
Table 4. Data for Calibration Curve Using Pararosaniline. 
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APPENDIX D 
Equations for Calculating Formaldehyde Concentrations in Air 
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When a Formaldehyde sample is developed, there are two absorbance 
values for each sample, one from each impinger. These two values are 
used in the equation below, to calculate the total ygrams of 
Formaldehyde. The total ygrams is later used to calculate the PPM of 
Formaldehyde. The sample volume is 20 ml, the aliquot is 2.5 ml. 
total yg = u9 A 
sample vol A 
aliquot A + U9 B 
sample vol B 
aliquot B 
It is also necessary to calculate the volume of air from which 
the Formaldehyde was removed. For this, the volume sampled (60 L) and 
the temperature in degrees Kelvin (°C + 273) are used in the 
equation below. 
V = V x 12®. 
corrected sampled T 
When the total ygrams and corrected volume are known, they are 
used in the equation below, to calculate the PPM concentration of 
Formaldehyde. 
nnu _ total yg X 24.47 
PPM ' v-\ "X 30.03 corrected 
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